By South Asia Monitor/JEN | @justearthnews | 16 Jun 2021, 08:29 am Print
Image: Wikimedia Commons
Bangladesh has approved Johnson and Johnson’s single-dose Covid-19 for emergency use in the country, making it the sixth vaccine to get approval. The country is all set to resume its national vaccination campaign on Saturday.
On Tuesday, the country’s Directorate-General of Drug Administration (DGDA) has granted emergency use approval to the vaccine after scrutinized all document and clinal trial data submitted by the manufacturer, reported Dhaka Tribune.
So far, it has approved six vaccines for usage in the country: AstraZeneca-Oxford vaccine, Sputnik-V, Pfizer, Sinopharm, and Sinovac. However, Astra-Zeneca and Sinopharm are the two main vaccines used for the national vaccination drive.
The supply of the Astra-Zeneca/Covishield vaccine was disrupted in April this year following the disastrous Covid-19 surge in India, prompting the Indian government to halt the export.
- Report suggests declines in global fertility rates set to transform global population pattern by 2100
- WHO says nearly 7000 avoidable deaths reported in Europe due to COVID-19 pandemic
- New study shows intermittent fasting may increase chances of death due to cardiovascular disease
- WHO study shows USD 39 return for each dollar invested in fight against TB
- Pakistan registers first polio case of 2024